Articles by: Geisel Communications

Ultra-Processed Foods: 3 Lesser-Known Health Effects—Healthline

Read article—Quotes Yiping Li, a PhD student in the Quantitative Biomedical Sciences Program, in coverage of research she co-authored that links higher consumption of ultra-processed foods to increased risk of prediabetes, particularly among younger adults. “These findings indicate that ultra-processed food consumption increases the risk for prediabetes and type 2 diabetes among young adults—and that limiting consumption of those foods can help prevent disease,” Li said.

Here’s What To Expect When Artemis II Reenters Earth, Splashes Down in Pacific Ocean (Video)—CBS News

Watch video—Quotes Jay Buckey, a professor of medicine and director of the Space Medicine Innovations Laboratory, on how the crew of the Artemis II mission prepares for returning to Earth. An astronaut aboard the Space Shuttle Columbia in 1998, Buckey discusses re-adapting to being on Earth and experiencing weightlessness in space, as well as his experience preparing for re-entry. “For us, it was a time to put the suits back on, get everything reconfigured in the spacecraft to get ready for re-entry, and then, you’re pretty much along for the ride,” Buckey said. (Buckey’s comments begin at 2:47)

Featured Gig: Asst. Dir., Master of Health Admin, Dartmouth—Inside Higher Ed

Read article—Joshua Kim, assistant provost for online learning strategy, interviews Katherine Milligan ’90, Tuck ’07, adjunct professor and associate dean for health care management education, about the master of health administration hybrid degree program and the search for an assistant director. “This role realizes institutional strategy through consistent, high-quality program delivery characterized by continuous improvement,” Milligan said.

Could a Blood Pressure Pill Improve the Health of Cancer Patients? Here’s What to Know—PennLive

Read article—Tyler Curiel, a professor of medicine, talks about his study reporting that the blood-pressure medicine Telmisartan may enhance the efficacy of cancer treatments known as PARP inhibitors. “This study shows that a common, safe, tolerable, convenient, and inexpensive drug may significantly improve how well an important class of cancer therapies works,” Curiel said.